35264-06-3 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTYL-ACETIC ACID is used as a building block for the synthesis of various pharmaceuticals and biologically active molecules. The presence of the Boc group allows for selective manipulation of the amine functionality, which is crucial for the development of new drugs with specific therapeutic properties.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTYL-ACETIC ACID is used as a versatile intermediate for the preparation of complex organic molecules. The cyclopentyl group provides rigidity to the molecule, which can be beneficial for specific applications, such as the synthesis of natural products or the development of novel chemical entities with unique biological activities.
Used in Drug Development:
(S)-TERT-BUTOXYCARBONYLAMINO-CYCLOPENTYL-ACETIC ACID is utilized in drug development as a key component in the design and synthesis of new therapeutic agents. Its unique structural features, including the Boc protecting group and the cyclopentyl ring, enable the creation of molecules with improved pharmacokinetic and pharmacodynamic properties, ultimately leading to more effective treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 35264-06-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,2,6 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 35264-06:
(7*3)+(6*5)+(5*2)+(4*6)+(3*4)+(2*0)+(1*6)=103
103 % 10 = 3
So 35264-06-3 is a valid CAS Registry Number.
35264-06-3Relevant academic research and scientific papers
Kazmaier, Uli,Paehler, Saskia,Endermann, Rainer,Haebich, Dieter,Kroll, Hein-Peter,Riedl, Bernd
, p. 3905 - 3913 (2002)
Several types of furanomycin analogues were synthesized and investigated with respect to their antibacterial activity. Two different synthetic pathways were developed, based on aldol reactions/ring closing metathesis and an ester enolate Claisen rearrangement. Only the natural product and its desmethyl derivative showed antibacterial activity, pointing towards a narrow structure-activity relationship.
Protected amino hydroxy adamantane carboxylic acid and process for its preparation
-
Paragraph 0337-0339; 0432; 0433, (2015/11/24)
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided. The provided compounds can be used for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.
